arrow
Back
P

Przemysław Kotyla

Medical University of Silesia

17H-index
139Paper Count
1.0KCitation Count
Published Papers 20
Publication Date
errShare
errSave
The protocol for a patient-driven online prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis among people living with psoriasis: the HIPPOCRATES Prospective Observational Study
err2026-03-25
err0
PREAI
errTeresa Grohmann; Timeo Mtenga; David Kerr; Joe Barrett; Nathanael Gray; Heidi Bertheussen; Juan D. Cañete; Kurt de Vlam; Maarten de Wit; Theodoros Dimitroulas; Sam Groothuizen; Glenn Haugeberg; Mari Hoff; Rudolf Horváth; Jana Hurnakova; Michaela Koehm; Przemyslaw Kotyla; Jean-Guillaume Letarouilly; Rik Lories; Mari Løset; Christine Möser; Burkhard Möller; Maria Mytilinaiou; Mikkel Østergaard; Ana Rodrigues; Caitriona Ryan; Carlo Selmi; Liv Eidsmo; Axel Svedbom; Tiago Torres; Florentin Ananu Vreju; Marleen G. H. van de Sande; Lars Werner; Stephen R. Pennington; Oliver FitzGerald; Laura C. Coates
errShare
errSave
Inflammation in Older Poles with Localized and Widespread Chronic Pain-Results from a Population-Based PolSenior Study
err2024-10-01
err1
errOAAI
errChudek, Anna; Kotyla, Przemyslaw; Kozak-Szkopek, Elzbieta; Mossakowska, Malgorzata; Wieczorowska-Tobis, Katarzyna; Sulicka-Grodzicka, Joanna; Olszanecka-Glinianowicz, Magdalena; Chudek, Jerzy; Owczarek, Aleksander J.
errShare
errSave
Vitamin D Status in Patients with Primary Antiphospholipid Syndrome (PAPS): A Systematic Review and Meta-Analysis
err2024-03-13
err3
errOAAI
errIslam, Md Asiful; Ahmed, Saleh; Sultana, Shabiha; Alam, Sayeda Sadia; Hossan, Tareq; Gouda, Wesam; Alsaqabi, Faisal; Hassan, Rosline; Kotyla, Przemyslaw J.
errShare
errSave
Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis
err2023-07-27
err4
errOAAI
errGumkowska-Sroka, Olga; Kotyla, Kacper; Mojs, Ewa; Palka, Klaudia; Kotyla, Przemyslaw
errShare
errSave
Plasma and Urine Levels of Glycosaminoglycans in Patients with Systemic Sclerosis and Their Relationship to Selected Interleukins and Marker of Early Kidney Injury
err2022-10-27
err2
errOAAI
errKuznik-Trocha, Kornelia; Winsz-Szczotka, Katarzyna; Komosinska-Vassev, Katarzyna; Jura-Poltorak, Agnieszka; Miara, Adrian; Kotyla, Przemyslaw; Olczyk, Krystyna
errShare
errSave
Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus
err2022-07-28
err16
errOAAI
errKotyla, Przemyslaw; Gumkowska-Sroka, Olga; Wnuk, Bartosz; Kotyla, Kacper
errShare
errSave
CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis
err2021-10-01
err0
errOAAI
errGieszczyk-Strozik, Klaudia; Wybraniec, Maciej T.; Widuchowska, Malgorzata; Brzezinska-Wcislo, Ligia; Kotyla, Przemyslaw; Kucharz, Eugeniusz; Mizia-Stec, Katarzyna
errShare
errSave
The prevalence and role of functional autoantibodies to angiotensin-converting-enzyme-2 in patients with systemic sclerosis
err2021-04-29
err14
PREAI
errMiziolek, Bartosz; Sienczyk, Marcin; Grzywa, Renata; Lupicka-Slowik, Agnieszka; Kucharz, Eugeniusz; Kotyla, Przemyslaw; Bergler-Czop, Beata
errShare
errSave
Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review
err2020-07-22
err70
errOAAI
errIslam, Md Asiful; Khandker, Shahad Saif; Kotyla, Przemyslaw J.; Hassan, Rosline
errShare
errSave
Significance of the angiotensin I/angiotensin II/angiotensin-(1-7) axis in the pathogenesis of systemic sclerosis
err2019-12-18
err12
PREAI
errMiziolek, B.; Bergler-Czop, B.; Kucharz, E.; Kotyla, P.; Kopec-Medrek, M.; Widuchowska, M.; Sienczyk, M.; Brzezinska-Wcislo, L.
errShare
errSave
Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis
err2019-11-01
err86
PREAI
errIslam, Md Asiful; Khandker, Shahad Saif; Alam, Sayeda Sadia; Kotyla, Przemyslaw; Hassan, Rosline
errShare
errSave
Cytometric Characterization of Main Immunocompetent Cells in Patients with Systemic Sclerosis: Relationship with Disease Activity and Type of Immunosuppressive Treatment
err2019-05-08
err16
errOAAI
errGumkowska-Sroka, Olga; Jagoda, Krystyna; Owczarek, Aleksander; Helbig, Grzegorz; Giemza-Stoklosa, Joanna; Kotyla, Przemyslaw J.
errShare
errSave
Fibroblast Growth Factor 23 to Alpha-Klotho Index Correlates with Systemic Sclerosis Activity: A Proposal for Novel Disease Activity Marker
err2018-12-17
err16
errOAAI
errKotyla, Przemyslaw J.; Kruszec-Zytniewska, Aneta; Owczarek, Aleksander J.; Olszanecka-Glinianowicz, Magdalena; Chudek, Jerzy
errShare
errSave
errShare
errSave